Fujifilm Medical to add IVD to portfolio

By AuntMinnie.com staff writers

August 17, 2020 -- Fujifilm Medical Systems USA has announced that as of October 1, it will incorporate in vitro diagnostics (IVD) into its portfolio by integrating Fujifilm Wako Diagnostics USA into the firm.

Fujifilm Wako Diagnostics has developed biomarkers that assess the risk of hepatocellular carcinoma in patients with chronic liver disease, as well as IVD reagents for disorders of lipid metabolism, lupus, rheumatoid arthritis, coronary heart disease, and diabetes, according to Fujifilm Medical Systems.


Copyright © 2020 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: